Juan-Ignacio Alós
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 14
-
- Antibiotic Resistance in Bacteria 31
- Co-authors
- J.L. Gómez‐GarcésJesús OteoDavid M. AranaFernando BaqueroM GobernadoM BaqueroRafael CantónJesús Blázquez
- Journals
- Clinical Microbiology and Infection (8 papers)Antimicrobial Agents and Chemotherapy (5 papers)Journal of Clinical Microbiology (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)International Journal of Antimicrobial Agents (2 papers)
- Partner nations
- SpainNetherlandsFrance
In The Last Decade
Juan-Ignacio Alós
93 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 111
- Molecular Medicine 603
- Applied Microbiology and Biotechnology 160
- Endocrinology 326
- Clinical Biochemistry 311
- Epidemiology 868
Countries citing papers authored by Juan-Ignacio Alós
This map shows the geographic impact of Juan-Ignacio Alós's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan-Ignacio Alós with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan-Ignacio Alós more than expected).
Fields of papers citing papers by Juan-Ignacio Alós
This network shows the impact of papers produced by Juan-Ignacio Alós. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan-Ignacio Alós. The network helps show where Juan-Ignacio Alós may publish in the future.
Co-authors
The 25 scholars most cited alongside Juan-Ignacio Alós, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 2 | |
| 3 | 2021 | 9 | |
| 4 | 2017 | 6 | |
| 5 | 2015 | 10 | |
| 6 | Primer aislado clínico de Streptococcus grupo B con resistencia a clindamicina mediada por el gen lnu(B) en Europa | 2014 | 14 |
| 7 | 2008 | 59 | |
| 8 | 2007 | 13 | |
| 9 | Coste biológico asociado a la resistencia a la fosfomicina en aislamientos de Escherichia coli de orina | 2007 | 11 |
| 10 | Sensibilidad a los antimicrobianos de aislamientos de Escherichia coli de mujeres con cistitis no complicada durante un periodo de un año en España | 2007 | 32 |
| 11 | 2007 | 10 | |
| 12 | 2007 | 7 | |
| 13 | 2005 | 55 | |
| 14 | 2005 | 42 | |
| 15 | 2004 | 17 | |
| 16 | 2002 | 22 | |
| 17 | 2001 | 9 | |
| 18 | 1998 | 13 | |
| 19 | [Prevalence of antimicrobial resistance in enterococci isolated from blood in Madrid (1994-1995)]. | 1997 | 6 |
| 20 | 1995 | 18 |
About Juan-Ignacio Alós
Juan-Ignacio Alós is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Endocrinology, Clinical Biochemistry and Infectious Diseases, having authored 95 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (31 papers), Streptococcal Infections and Treatments (21 papers), Urinary Tract Infections Management (19 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Bacterial Identification and Susceptibility Testing (15 papers), Pneumonia and Respiratory Infections (14 papers), Antibiotic Use and Resistance (14 papers) and Enterobacteriaceae and Cronobacter Research (11 papers). The work is most often cited by research in Molecular Medicine (603 citations), Applied Microbiology and Biotechnology (160 citations), Endocrinology (326 citations), Clinical Biochemistry (311 citations) and Epidemiology (868 citations). Juan-Ignacio Alós has collaborated with scholars based in Spain, Netherlands and France. Frequent co-authors include J.L. Gómez‐Garcés, Jesús Oteo, David M. Arana, Fernando Baquero, M Gobernado, M Baquero, Rafael Cantón, Jesús Blázquez, Margarita Rubio Alonso and P. García-Hierro. Their work appears in journals such as Clinical Microbiology and Infection, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.